Hyperglycemia  >>  Januvia (sitagliptin)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Januvia (sitagliptin) / Merck (MSD)
NCT00947011: Dipeptidyl Peptidase-4 Inhibition on Glucagon-like Peptide-1 (GLP-1)

Terminated
2
12
US
Placebo, Sugar pill, Januvia, Sitagliptin
Johns Hopkins University, Merck Sharp & Dohme LLC
Glucose Homeostasis
03/10
03/10
NCT00451113: Sitagliptin in the Elderly

Completed
2
12
Canada
Sitagliptin 100 mg, Januvia, MK-0431, Dipeptidyl peptidase IV inhibitor (DPP-4 inhibitor)
University of British Columbia, Merck Frosst Canada Ltd.
Type 2 Diabetes
11/12
11/12

Download Options